FTNT vs. NBIX
FTNT (Fortinet, Inc.) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. FTNT operates in Software - Infrastructure (Technology), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, FTNT returned 36.02%/yr vs 13.16%/yr for NBIX. At a 0.29 correlation, their price movements are largely independent.
Performance
FTNT vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTNT achieves a 84.23% return, which is significantly higher than NBIX's 12.64% return. Over the past 10 years, FTNT has outperformed NBIX with an annualized return of 36.02%, while NBIX has yielded a comparatively lower 13.16% annualized return.
FTNT
- 1D
- 0.85%
- 1M
- 24.31%
- YTD
- 84.23%
- 6M
- 77.94%
- 1Y
- 43.91%
- 3Y*
- 27.56%
- 5Y*
- 26.15%
- 10Y*
- 36.02%
NBIX
- 1D
- -1.81%
- 1M
- -0.97%
- YTD
- 12.64%
- 6M
- 4.55%
- 1Y
- 27.80%
- 3Y*
- 18.64%
- 5Y*
- 10.13%
- 10Y*
- 13.16%
FTNT vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTNT Fortinet, Inc. | 84.23% | -15.95% | 61.42% | 19.72% | -31.98% | 141.97% | 39.13% | 51.58% | 61.20% | 45.05% |
NBIX Neurocrine Biosciences, Inc. | 12.64% | 3.90% | 3.60% | 10.31% | 40.24% | -11.14% | -10.83% | 50.53% | -7.96% | 100.49% |
Correlation
The correlation between FTNT and NBIX is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Nov 18, 2009 | 0.29 |
The correlation between FTNT and NBIX shifts across timeframes, from 0.13 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.
Fundamentals
FTNT:
$108.67B
NBIX:
$16.52B
FTNT:
$2.58
NBIX:
$6.53
FTNT:
56.81
NBIX:
24.46
FTNT:
1.58
NBIX:
0.48
FTNT:
15.62
NBIX:
5.27
FTNT:
109.80
NBIX:
4.85
FTNT:
$7.11B
NBIX:
$3.10B
FTNT:
$5.74B
NBIX:
$3.05B
FTNT:
$2.47B
NBIX:
$881.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTNT vs. NBIX — Risk / Return Rank
FTNT
NBIX
FTNT vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fortinet, Inc. (FTNT) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FTNT | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.10 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.19 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.43 | 1.34 | +0.09 |
| Martin ratioReturn relative to average drawdown | 2.09 | 2.94 | -0.84 |
Loading charts...
Drawdowns
FTNT vs. NBIX - Drawdown Comparison
The maximum FTNT drawdown since its inception was -51.20%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for FTNT and NBIX.
Loading charts...
Drawdown Indicators
| FTNT | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.20% | -97.21% | +46.01% |
Max Drawdown (1Y)Largest decline over 1 year | -30.90% | -20.90% | -10.00% |
Max Drawdown (3Y)Largest decline over 3 years | -38.32% | -42.89% | +4.57% |
Max Drawdown (5Y)Largest decline over 5 years | -38.32% | -42.89% | +4.57% |
Max Drawdown (10Y)Largest decline over 10 years | -38.32% | -46.39% | +8.07% |
Current DrawdownCurrent decline from peak | -2.25% | -4.54% | +2.29% |
Average DrawdownAverage peak-to-trough decline | -16.22% | -43.84% | +27.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.07% | 9.49% | +11.58% |
Volatility
FTNT vs. NBIX - Volatility Comparison
Fortinet, Inc. (FTNT) has a higher volatility of 13.35% compared to Neurocrine Biosciences, Inc. (NBIX) at 9.63%. This indicates that FTNT's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTNT | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.35% | 9.63% | +3.72% |
Volatility (6M)Calculated over the trailing 6-month period | 31.79% | 23.91% | +7.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.18% | 31.38% | +13.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.94% | 32.73% | +11.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.88% | 39.13% | +1.75% |
Dividends
FTNT vs. NBIX - Dividend Comparison
Neither FTNT nor NBIX has paid dividends to shareholders.
Financials
FTNT vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Fortinet, Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
FTNT vs. NBIX - Profitability Comparison
FTNT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Fortinet, Inc. reported a gross profit of 1.49B and revenue of 1.85B. Therefore, the gross margin over that period was 80.3%.
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
FTNT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Fortinet, Inc. reported an operating income of 580.00M and revenue of 1.85B, resulting in an operating margin of 31.4%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
FTNT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Fortinet, Inc. reported a net income of 534.50M and revenue of 1.85B, resulting in a net margin of 28.9%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
Frequently Asked Questions
FTNT and NBIX have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FTNT has higher volatility (13.35%) compared to NBIX (9.63%). In terms of maximum drawdown, FTNT dropped -51.20% vs NBIX's -97.21%.
FTNT currently has the higher Sharpe Ratio (0.98 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTNT and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer